Table 4

Randomised comparison of medical treatment with PCI in patients with stable CAD

		ACME (6 months follow up)				RITA-2 (32 months follow up)				AVERT (18 months follow up)
		Medical treatment (antianginals) (n=107)	PCI (PTCA) (n=105)			Medical treatment (antianginals) (n=514)	PCI (PTCA) (n=504)			Medical treatment (atorvastatin) (n=164)	PCI (PTCA, stent) (n=177)
End points	% of patients
Death	0.9	0			1.4	2.2			0.6	0.6
MI	2.8	4.8			1.9	4.1			2.4	2.8
Death or MI	3.7	4.8			3.3	6.3^4-151			3.0	3.4
Angina
Free	53.9	36.5^4-160		–	–		–	–
Improved	–	–			–	–^4-152			41	54^4-150
CABG	0	7^4-160			5.8	7.9			1.2	5.1
PTCA	9	16			17.1	11.1			11.0	11.9
Repeat hospitalisation	–	–			–	–			6.7	14.1

↵4-150 p < 0.05;
↵4-151 p < 0.02;
↵4-160 p < 0.01;
↵4-152 17% excess of grade 2+ angina in the medical group 3 months after randomisation.